Aptose Biosciences Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Lease Liability (Tables)

6 Months Ended

Jun. 30, 2023

Minimum payments, undiscounted, under our operating leases are as follows:

The following table presents the weighted average remaining term of the leases and the weighted average discount rate:


	June 30, 2023			December 31, 2022
Weighted-average remaining term – operating leases (years)		2.8			3.3
Weighted-average discount rate – operating leases		7.38	%		6.62	%

Lease liability, current portion	$	387		$	301
Lease liability, long-term portion		817			1,002
Total	$	1,204		$	1,303

Operating lease costs and operating cash flows from our operating leases are as follows:


	Three months ended June 30,				Six months ended June 30,
	2023		2022		2023		2022
Operating lease cost	$	117	$	117	$	245	$	238
Operating cash flows from operating leases	$	45	$	134	$	173	$	277